Odyssey Health (ODYY) Depreciation & Amortization (CF) (2016 - 2024)
Odyssey Health's (ODYY) quarterly Depreciation & Amortization (CF) came in at $594.0 in Q1 2024, down 21.22% year-on-year from $754.0 in Q1 2023, and down 37.08% quarter-over-quarter from $944.0 in Q4 2023.
Odyssey Health (ODYY) Depreciation & Amortization (CF) (2016 - 2024) Analysis & Trends
Odyssey Health's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $594.0 for Q1 2024.
- On a quarterly basis, Depreciation & Amortization (CF) fell 21.22% year-over-year to $594.0 in Q1 2024; TTM through Oct 2024 was $594.0, a 83.53% decrease from a year earlier, with the FY2024 full-year figure at $1538.0, down 54.98% from the prior year.
- Depreciation & Amortization (CF) fell to $594.0 in Q1 2024 per ODYY's latest filing, from $944.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2639.0 in Q2 2020 and bottomed at -$3039.0 in Q3 2021.
- The 5-year median for Depreciation & Amortization (CF) is $892.0 (2022), against an average of $1097.5.
- Across the five-year window, Depreciation & Amortization (CF) sank 215.24% in 2021 and soared 551.09% in 2022, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $2638.0 in 2020, then tumbled by 94.77% to $138.0 in 2021, then jumped by 446.38% to $754.0 in 2022, then grew by 25.2% to $944.0 in 2023, then sank by 37.08% to $594.0 in 2024.
- Per Business Quant, the three latest ODYY Depreciation & Amortization (CF) figures stand at $594.0 (Q1 2024), $944.0 (Q4 2023), and $887.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2024 | 594.00 |
| Jan 31, 2024 | 594.00 |
| Oct 31, 2023 | 944.00 |
| Oct 31, 2023 | 944.00 |
| Jul 31, 2023 | 887.00 |
| Jul 31, 2023 | 887.00 |
| Apr 30, 2023 | 1,021.00 |
| Apr 30, 2023 | 1,021.00 |
| Jan 31, 2023 | 754.00 |
| Jan 31, 2023 | 754.00 |
| Oct 31, 2022 | 754.00 |
| Oct 31, 2022 | 754.00 |
| Jul 31, 2022 | 1,796.00 |
| Jul 31, 2022 | 1,796.00 |
| Apr 30, 2022 | 892.00 |
| Apr 30, 2022 | 892.00 |
| Jan 31, 2022 | 590.00 |
| Jan 31, 2022 | 590.00 |
| Oct 31, 2021 | 138.00 |
| Oct 31, 2021 | 138.00 |